YOLFTbeta
SonoScape Medical Corp

SonoScape Medical Corp

300633 · SHE · Healthcare / Medical Devices

21.37CNY+0.07 (+0.33%)

Price History

Full chart

Market Stats

Previous Close21.30
Open21.26
Day Range21.03 – 21.95
52-Week Range17.20 – 35.12
Volume4.98M
Market Cap8.25B
P/E (TTM)51.11
Forward P/E0.00
EPS0.38
Dividend Yield0.93%
Beta-0.49
50-Day Avg19.79
200-Day Avg23.24

About

SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. It offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image processors, light sources, gastroenterology and pulmonology products, endoscopic ultrasound, duodenoscopes, and peripheral equipment; minimally invasive surgery solutions, such as camera systems and flexible endoscopes; veterinary ultrasound and endoscopy solutions; and intravascular intervention products. The company also provides face-to-face and online training for ultrasound and endoscopy systems; technical and spare parts support; preventive maintenance, calibration, breakdown repair, and other field services; and upgrade services. In addition, it is involved in the software industry. SonoScape Medical Corp. was incorporated in 2002 and is headquartered in Shenzhen, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Kunxiang Wu
  • Employees3.13K
  • HeadquartersKaili Medical Building, Shenzhen, China, 518107, China
  • Websitehttps://www.sonoscape.com

Leadership

  • Mr. Kunxiang WuGM & Director · b. 1963
  • Mr. Yuezuo LuoChief Financial Officer · b. 1983
  • Mr. Yibo HuangDeputy GM & Director · b. 1966
  • Nai Zhang FengDeputy GM & Director · b. 1975
  • Mr. Hao LiBoard Secretary & Deputy GM · b. 1978
  • Mr. Xiang LiDeputy General Manager · b. 1984
  • Tingting XuAccounting Supervisor

Financials

Income Statement

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue484.25M592.24M639.72M685.83M719.36M989.07M1.23B1.25B1.16B1.44B1.76B2.12B2.01B2.31B
Growth (%)-+22.30%+8.02%+7.21%+4.89%+37.49%+24.04%+2.20%-7.24%+24.20%+22.02%+20.29%-5.02%+14.65%
Cost of Revenue209.14M232.06M236.42M256.30M255.52M315.97M380.75M444.36M409.79M533.13M624.18M720.30M786.29M877.69M
Gross Profit275.10M360.19M403.30M429.53M463.83M673.10M846.10M809.50M753.30M911.46M1.14B1.40B1.23B1.43B
Gross Margin56.81%60.82%63.04%62.63%64.48%68.05%68.97%64.56%64.77%63.09%64.59%66.03%60.96%61.99%
Operating Expense147.74M302.47M283.29M353.61M384.63M465.42M574.37M702.88M797.47M695.80M756.04M925.14M1.11B1.25B
Operating Income127.36M57.72M120.01M75.93M79.21M207.68M271.73M106.62M-44.17M215.66M382.43M474.81M121.56M184.45M
Operating Margin26.30%9.75%18.76%11.07%11.01%21.00%22.15%8.50%-3.80%14.93%21.70%22.39%6.04%7.99%
EBITDA130.12M152.56M138.38M90.15M90.26M199.76M269.32M122.22M171.25M247.77M356.61M507.71M163.86M271.09M
EBITDA Margin26.87%25.76%21.63%13.14%12.55%20.20%21.95%9.75%14.72%17.15%20.23%23.95%8.14%11.74%
Net Income129.94M70.65M131.75M105.87M130.43M190.02M252.62M101.54M-46.26M247.24M369.81M454.44M142.40M197.28M
Net Income Margin26.83%11.93%20.60%15.44%18.13%19.21%20.59%8.10%-3.98%17.12%20.98%21.43%7.07%8.54%
R&D-71.43M91.65M124.14M133.80M176.93M233.49M254.91M237.42M263.06M328.96M384.26M472.93M495.78M
R&D as % of Total Revenue-12.06%14.33%18.10%18.60%17.89%19.03%20.33%20.41%18.21%18.66%18.12%23.48%21.47%
Interest Expense1.07M6.77M7.46M4.70M4.11M3.11M2.57M17.78M20.01M7.91M5.91M8.83M9.79M4.16M
Interest Expense % of Total Revenue0.22%1.14%1.17%0.68%0.57%0.31%0.21%1.42%1.72%0.55%0.34%0.42%0.49%0.18%

Balance Sheet

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets621.41M625.75M858.30M935.73M1.02B1.34B1.84B2.41B2.25B3.02B3.54B3.77B4.31B4.41B
Total Liabilities269.59M260.67M413.48M369.52M296.44M275.93M524.67M1.01B906.93M665.18M804.41M625.46M1.20B1.14B
Total Equity333.95M365.08M444.81M566.21M720.11M1.06B1.31B1.40B1.34B2.36B2.74B3.15B3.11B3.26B
Cash87.35M98.89M242.22M184.17M217.40M71.03M130.74M167.39M544.26M1.27B1.34B1.77B1.57B1.43B
Total Debt85.86M25.93M209.38M149.26M66.33M23.35M169.07M460.64M446.88M110.74M218.89M57.64M338.20M-
Net Debt-1.49M-72.96M-32.84M-34.91M-151.07M-47.68M38.34M293.26M-97.38M-1.16B-1.12B-1.70B-1.23B-

Cash Flow

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow15.49M89.94M113.55M56.29M137.38M136.21M233.65M190.39M271.13M302.99M473.26M493.88M306.66M-48.16M
Investing Cash Flow-142.82M8.86M-149.53M-57.12M-10.16M-342.76M-305.03M-483.37M208.16M71.53M-434.06M186.17M-591.14M-
Financing Cash Flow44.52M-91.16M128.86M-65.22M-86.97M108.54M116.54M327.14M-76.59M357.33M3.78M-275.52M82.24M-
Capital Expenditure22.41M49.25M16.60M16.21M13.89M45.35M80.88M158.79M155.29M152.25M190.32M176.99M206.86M142.24M
Free Cash Flow-6.92M40.69M96.95M40.08M123.49M90.86M152.77M31.60M115.84M150.74M282.93M312.48M99.80M-190.40M
Dividends Paid41.35M31.22M65.64M5.10M4.04M15.57M21.69M26.00M10.50M5.54M53.48M82.72M144.34M47.23M
FCF to OCF-44.66%45.24%85.38%71.21%89.89%66.71%65.38%16.60%42.72%49.75%59.78%63.27%32.54%395.36%
Dividend Paid to FCF-597.78%76.73%67.71%12.72%3.27%17.13%14.20%82.28%9.06%3.68%18.90%26.47%144.63%-24.81%

Earnings

Report DateAug 18, 2017Oct 26, 2017Apr 24, 2018Aug 3, 2018Oct 28, 2018Apr 24, 2019Aug 27, 2019Oct 28, 2019Feb 28, 2020Apr 22, 2020Aug 25, 2020Oct 28, 2020Apr 23, 2021Aug 17, 2021Oct 28, 2021Apr 14, 2022Aug 23, 2022Oct 25, 2022Dec 31, 2022Apr 26, 2023Aug 22, 2023Oct 25, 2023Feb 2, 2024Apr 11, 2024Aug 28, 2024Oct 25, 2024Dec 31, 2024Apr 11, 2025Aug 21, 2025Oct 28, 2025Dec 31, 2025Apr 28, 2026Aug 21, 2026
EPS Estimate------------------0.260.260.280.280.180.180.330.320.090.090.160.130.230.130.05
EPS Actual0.160.100.050.240.130.210.15-0.020.090.100.080.000.090.180.080.120.290.170.290.290.340.110.300.310.16-0.140.080.080.09-0.030.35-0.030.06
Surprise------------------11.54%11.54%21.43%-60.71%66.67%72.22%-51.52%-143.75%-16.15%-11.11%-43.75%-123.08%51.20%-123.08%20.00%
TimingPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hours-Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-market-Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-market

Key Statistics & Ratios

Market Cap8.25B
Enterprise Value7.60B
Trailing P/E51.11
Forward P/E0.00
Price / Sales3.44
Price / Book2.78
EPS0.38
Book Value7.14
Revenue (TTM)2.40B
Gross Profit (TTM)1.43B
EBITDA221.87M
Profit Margin6.84%
Operating Margin2.85%
Return on Equity5.35%
Return on Assets2.07%
Shares Outstanding424.84M
Shares Float182.57M
Beta-0.49
Dividend Yield0.93%
Dividend Rate0.18
Payout Ratio51.22%

Dividends

20261×
0.18Jun 5, 2026
20251×
0.10May 29, 2025
20241×
0.32May 29, 2024
20231×
0.18Jun 8, 2023
20221×
0.13Jul 15, 2022
20201×
0.03Jul 10, 2020
20191×
0.07Jun 13, 2019
20181×
0.05May 18, 2018
20171×
0.03Jun 22, 2017